NCT07056829

Brief Summary

The aim of this study is to compare the effectiveness of two different orthodontic treatment methods used in patients with skeletal Class II malocclusion, a condition in which the lower jaw is positioned backward. Approximately 80% of Class II malocclusions are due to mandibular retrusion. Therefore, functional appliances that stimulate mandibular growth in growing individuals have been widely used in orthodontics for many years. In recent years, clear aligner systems have become increasingly popular in orthodontic practice. A mandibular advancement feature was recently integrated into these aligners, allowing for simultaneous tooth alignment and forward positioning of the lower jaw. In this study, the newly developed Mandibular Advancement Appliance (MAA), based on clear aligners, will be compared to the traditional functional appliance known as the Activator. Who Can Participate in the Study? Children with retrusive lower jaws who are in the growth and development period Individuals with no prior orthodontic treatment Patients with specific levels of dental protrusion (overjet) Those with good general health and no contraindications for CBCT imaging What Will the Treatment Process Involve? Participants will be randomly assigned to one of three groups: MAA group (clear aligners with mandibular advancement) Activator group (traditional removable appliance) Control group (no treatment, only observation) The active treatment period will last approximately 7-8 months, followed by a retention phase. All patients will be monitored regularly, and strict adherence to appliance use will be expected. How Will the Outcomes Be Assessed? Before and after the treatment period, participants will undergo cone-beam computed tomography (CBCT) scans to obtain detailed three-dimensional images of the jaws. These images will be analyzed to evaluate volumetric changes. All measurements will be performed by a trained orthodontic specialist using dedicated software. Potential Benefits for Participants: Participants will receive close clinical monitoring throughout the study period. The use of advanced imaging technologies may support the development of more effective and individualized treatment plans. Safety and Confidentiality: This study has received ethical approval and will be conducted in accordance with relevant data protection and research ethics standards. All personal data will be kept confidential. Written informed consent will be obtained from all participants and/or their legal guardians.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

June 29, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 9, 2025

Completed
Last Updated

July 9, 2025

Status Verified

June 1, 2025

Enrollment Period

1 month

First QC Date

June 29, 2025

Last Update Submit

June 29, 2025

Conditions

Keywords

clear alignersmandibular retrognathiamandibular advancement

Outcome Measures

Primary Outcomes (1)

  • Change in mandibular volume (mm³)

    Mandibular volume change will be measured using CBCT scans analyzed via Mimics software. The MAA and Activator groups will be compared to evaluate treatment effects.

    Baseline and post-treatment (~8 months)

Study Arms (3)

MAA Group

EXPERIMENTAL

Patients receive orthodontic treatment using clear aligners (Invisalign) with integrated mandibular advancement features (MAA). Advancement is performed in 2 mm increments every 8 weeks over \~8 months.

Device: Mandibular Advancement Appliance (Invisalign MA)

Activator Group

ACTIVE COMPARATOR

Patients receive traditional removable functional appliance therapy (Activator) for \~7 months.

Device: Activator Appliance

Control Group

NO INTERVENTION

Patients receive no orthodontic treatment but are monitored for the same duration as the treatment groups.

Interventions

Clear aligner system with integrated buccal precision wings to posture the mandible forward. Advancement protocol: 2 mm increments every 8 weeks. Total active treatment duration: \~8.15 months, followed by retention phase. Patients instructed to wear aligners ≥20 h/day, removing only for eating and oral hygiene.

MAA Group

Traditional removable functional appliance fabricated on a standardized bite registration. Patients instructed to wear appliance 24 h/day except during meals and sports. Total active treatment duration: \~7.15 months, followed by retention phase.

Activator Group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Cervical vertebral maturation (CVM) stage 2 or 3
  • Bilateral full or half cusp Class II molar relationship
  • Skeletal Class II relationship associated with mandibular retrognathia (ANB angle \> 4° and SNB angle \< 78°)
  • Horizontal or average growth pattern (SN-GoGn ≤ 38°)
  • Overjet distance between +4 mm and +8 mm; (6) Good patient compliance throughout the treatment.

You may not qualify if:

  • CVM stage 5 or 6;(2) Previous orthodontic treatment;
  • Presence of maxillary prognathism
  • High-angle growth pattern (SN-GoGn \> 38°)
  • Transverse orthodontic anomalies or facial asymmetry
  • Palpation-induced tenderness or pain in the masticatory muscles
  • Presence of clicking, crepitus, pain, or tenderness in the temporomandibular joint (TMJ)
  • Congenital or acquired craniofacial deformities
  • Poor patient compliance or oral hygiene
  • Any condition that could interfere with CBCT imaging.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Batman University Faculty of Dentistry

Batman, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Micrognathism

Interventions

Activator Appliances

Condition Hierarchy (Ancestors)

Jaw AbnormalitiesJaw DiseasesMusculoskeletal DiseasesMaxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesStomatognathic DiseasesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Orthodontic Appliances, FunctionalOrthodontic AppliancesOrthodonticsDentistryOrthodontic Appliances, Removable

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study follows a parallel assignment model. Participants are randomly assigned to one of three groups: the Mandibular Advancement Appliance (MAA) group, the Activator group, or the control group. Each group receives a different intervention or, in the case of the control group, no treatment, and all groups are observed over the same period without crossover between interventions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor Dr.

Study Record Dates

First Submitted

June 29, 2025

First Posted

July 9, 2025

Study Start

May 1, 2025

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

July 9, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations